|
MBOAT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.80310047080002E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34750013766916E-10 |
| Normal-vs-Stage2 |
2.02139999999629E-05 |
| Normal-vs-Stage3 |
2.262900E-03 |
| Normal-vs-Stage4 |
3.587500E-02 |
| Stage1-vs-Stage2 |
9.534200E-01 |
| Stage1-vs-Stage3 |
3.533000E-01 |
| Stage1-vs-Stage4 |
7.825400E-01 |
| Stage2-vs-Stage3 |
4.634200E-01 |
| Stage2-vs-Stage4 |
7.589000E-01 |
| Stage3-vs-Stage4 |
7.974600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20440002415734E-09 |
| Normal-vs-AfricanAmerican |
4.19210000046633E-08 |
| Normal-vs-Asian |
2.519500E-02 |
| Caucasian-vs-AfricanAmerican |
5.903600E-01 |
| Caucasian-vs-Asian |
4.737400E-01 |
| AfricanAmerican-vs-Asian |
4.507200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
5.424500E-03 |
| Male-vs-Female |
1.57447999999949E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.5851999997999E-07 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
2.93829999997719E-06 |
| Normal-vs-Extreme_Obese |
9.084300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.183800E-01 |
| Normal_Weight-vs-Obese |
6.194400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.047600E-01 |
| Extreme_Weight-vs-Obese |
2.998200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.652800E-01 |
| Obese-vs-Extreme_Obese |
9.266600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.703200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.2817999994752E-08 |
| Normal-vs-Age(61-80Yrs) |
1.47980516729262E-11 |
| Normal-vs-Age(81-100Yrs) |
2.42619999979432E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.031960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.458500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.756000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.881390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.279800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.648800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.7590373602161E-12 |
| Normal-VS-Type2 PRCC |
2.58237875527811E-12 |
| Normal-VS-KIRP CIMP |
5.334300E-02 |
| Normal-VS-Unclassified PRCC |
4.02479999994654E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.497440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.402500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.846800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.642900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.024000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.20370000000758E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3392399128852E-13 |
| Normal-vs-N1 |
5.020200E-02 |
| Normal-vs-N2 |
5.016400E-01 |
| N0-vs-N1 |
1.171860E-02 |
| N0-vs-N2 |
4.582000E-01 |
| N1-vs-N2 |
9.568400E-01 |
|
|
